nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—PDE4B—DARPP-32 events—PPP3R1—peripheral nervous system neoplasm	0.0237	0.0698	CbGpPWpGaD
Papaverine—PDE10A—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.0131	0.0386	CbGpPWpGaD
Papaverine—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.0116	0.018	CcSEcCtD
Papaverine—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.0116	0.018	CcSEcCtD
Papaverine—Trimethoprim—ABCB1—peripheral nervous system neoplasm	0.0109	0.708	CrCbGaD
Papaverine—PDE10A—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.00987	0.029	CbGpPWpGaD
Papaverine—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.00968	0.015	CcSEcCtD
Papaverine—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.00968	0.015	CcSEcCtD
Papaverine—PDE4B—Opioid Signalling—PPP3R1—peripheral nervous system neoplasm	0.00956	0.0281	CbGpPWpGaD
Papaverine—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.00955	0.0148	CcSEcCtD
Papaverine—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00898	0.0139	CcSEcCtD
Papaverine—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00898	0.0139	CcSEcCtD
Papaverine—Flushing—Melphalan—peripheral nervous system neoplasm	0.00887	0.0138	CcSEcCtD
Papaverine—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00879	0.0136	CcSEcCtD
Papaverine—PDE3B—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00851	0.025	CbGpPWpGaD
Papaverine—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.00791	0.0123	CcSEcCtD
Papaverine—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.00788	0.0122	CcSEcCtD
Papaverine—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.00782	0.0121	CcSEcCtD
Papaverine—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.00782	0.0121	CcSEcCtD
Papaverine—PDE3A—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00775	0.0228	CbGpPWpGaD
Papaverine—Malaise—Topotecan—peripheral nervous system neoplasm	0.00766	0.0119	CcSEcCtD
Papaverine—Malaise—Tretinoin—peripheral nervous system neoplasm	0.0076	0.0118	CcSEcCtD
Papaverine—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.0076	0.0118	CcSEcCtD
Papaverine—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00749	0.0116	CcSEcCtD
Papaverine—PDE4B—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00737	0.0217	CbGpPWpGaD
Papaverine—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00734	0.0114	CcSEcCtD
Papaverine—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.00733	0.0114	CcSEcCtD
Papaverine—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00714	0.0111	CcSEcCtD
Papaverine—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00709	0.011	CcSEcCtD
Papaverine—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00709	0.011	CcSEcCtD
Papaverine—PDE10A—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.00686	0.0202	CbGpPWpGaD
Papaverine—PDE10A—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00681	0.02	CbGpPWpGaD
Papaverine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00681	0.0106	CcSEcCtD
Papaverine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00661	0.0103	CcSEcCtD
Papaverine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00655	0.0102	CcSEcCtD
Papaverine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00655	0.0102	CcSEcCtD
Papaverine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00647	0.01	CcSEcCtD
Papaverine—PDE3B—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.00639	0.0188	CbGpPWpGaD
Papaverine—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00639	0.00992	CcSEcCtD
Papaverine—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.00621	0.00964	CcSEcCtD
Papaverine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00603	0.00935	CcSEcCtD
Papaverine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00598	0.00928	CcSEcCtD
Papaverine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00598	0.00928	CcSEcCtD
Papaverine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00593	0.0092	CcSEcCtD
Papaverine—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00592	0.00919	CcSEcCtD
Papaverine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.0059	0.00916	CcSEcCtD
Papaverine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00588	0.00913	CcSEcCtD
Papaverine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00588	0.00913	CcSEcCtD
Papaverine—PDE3A—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.00582	0.0171	CbGpPWpGaD
Papaverine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.0058	0.009	CcSEcCtD
Papaverine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00579	0.00899	CcSEcCtD
Papaverine—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00576	0.00894	CcSEcCtD
Papaverine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00571	0.00886	CcSEcCtD
Papaverine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00567	0.00879	CcSEcCtD
Papaverine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00567	0.00879	CcSEcCtD
Papaverine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00553	0.00858	CcSEcCtD
Papaverine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00537	0.00834	CcSEcCtD
Papaverine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00536	0.00831	CcSEcCtD
Papaverine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00531	0.00825	CcSEcCtD
Papaverine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00505	0.00783	CcSEcCtD
Papaverine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00497	0.00771	CcSEcCtD
Papaverine—PDE3B—PI3K Cascade—PTPN11—peripheral nervous system neoplasm	0.00496	0.0146	CbGpPWpGaD
Papaverine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00491	0.00761	CcSEcCtD
Papaverine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00489	0.00758	CcSEcCtD
Papaverine—PDE4B—G Protein Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00481	0.0141	CbGpPWpGaD
Papaverine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00479	0.00743	CcSEcCtD
Papaverine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00474	0.00736	CcSEcCtD
Papaverine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.0047	0.0073	CcSEcCtD
Papaverine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.0047	0.0073	CcSEcCtD
Papaverine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00464	0.00721	CcSEcCtD
Papaverine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00463	0.00719	CcSEcCtD
Papaverine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00462	0.00718	CcSEcCtD
Papaverine—PDE3B—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00458	0.0135	CbGpPWpGaD
Papaverine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00458	0.0071	CcSEcCtD
Papaverine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00453	0.00703	CcSEcCtD
Papaverine—Verapamil—ABCB1—peripheral nervous system neoplasm	0.00452	0.292	CrCbGaD
Papaverine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00449	0.00698	CcSEcCtD
Papaverine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00448	0.00695	CcSEcCtD
Papaverine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00446	0.00692	CcSEcCtD
Papaverine—PDE3B—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.00444	0.0131	CbGpPWpGaD
Papaverine—PDE3B—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00441	0.013	CbGpPWpGaD
Papaverine—Rash—Topotecan—peripheral nervous system neoplasm	0.00437	0.00678	CcSEcCtD
Papaverine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00437	0.00678	CcSEcCtD
Papaverine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00437	0.00677	CcSEcCtD
Papaverine—Headache—Topotecan—peripheral nervous system neoplasm	0.00434	0.00674	CcSEcCtD
Papaverine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00434	0.00673	CcSEcCtD
Papaverine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00434	0.00673	CcSEcCtD
Papaverine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00433	0.00672	CcSEcCtD
Papaverine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00433	0.00672	CcSEcCtD
Papaverine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00431	0.00669	CcSEcCtD
Papaverine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00431	0.00669	CcSEcCtD
Papaverine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00429	0.00666	CcSEcCtD
Papaverine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00429	0.00666	CcSEcCtD
Papaverine—Rash—Melphalan—peripheral nervous system neoplasm	0.00428	0.00664	CcSEcCtD
Papaverine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00428	0.00664	CcSEcCtD
Papaverine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00423	0.00657	CcSEcCtD
Papaverine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00419	0.00651	CcSEcCtD
Papaverine—PDE3B—IRS-mediated signalling—PTPN11—peripheral nervous system neoplasm	0.00415	0.0122	CbGpPWpGaD
Papaverine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00412	0.00639	CcSEcCtD
Papaverine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00408	0.00634	CcSEcCtD
Papaverine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00408	0.00634	CcSEcCtD
Papaverine—PDE3A—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.00404	0.0119	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—PTPN11—peripheral nervous system neoplasm	0.00403	0.0119	CbGpPWpGaD
Papaverine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00403	0.00626	CcSEcCtD
Papaverine—PDE3A—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00402	0.0118	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—PTPN11—peripheral nervous system neoplasm	0.004	0.0117	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—PTPN11—peripheral nervous system neoplasm	0.00389	0.0114	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—PTPN11—peripheral nervous system neoplasm	0.00389	0.0114	CbGpPWpGaD
Papaverine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00388	0.00602	CcSEcCtD
Papaverine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00386	0.00599	CcSEcCtD
Papaverine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00385	0.00597	CcSEcCtD
Papaverine—PDE4B—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00382	0.0112	CbGpPWpGaD
Papaverine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00366	0.00568	CcSEcCtD
Papaverine—PDE3B—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.00362	0.0106	CbGpPWpGaD
Papaverine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00357	0.00553	CcSEcCtD
Papaverine—PDE10A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00356	0.0105	CbGpPWpGaD
Papaverine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00354	0.0055	CcSEcCtD
Papaverine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00354	0.00549	CcSEcCtD
Papaverine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00348	0.0054	CcSEcCtD
Papaverine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00344	0.00533	CcSEcCtD
Papaverine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00335	0.0052	CcSEcCtD
Papaverine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00334	0.00518	CcSEcCtD
Papaverine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00329	0.0051	CcSEcCtD
Papaverine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00328	0.00509	CcSEcCtD
Papaverine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00326	0.00507	CcSEcCtD
Papaverine—PDE3B—Signaling by Insulin receptor—PTPN11—peripheral nervous system neoplasm	0.00323	0.0095	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00323	0.0095	CbGpPWpGaD
Papaverine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00321	0.00498	CcSEcCtD
Papaverine—PDE4B—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.0032	0.00939	CbGpPWpGaD
Papaverine—Rash—Vincristine—peripheral nervous system neoplasm	0.00317	0.00491	CcSEcCtD
Papaverine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00316	0.00491	CcSEcCtD
Papaverine—Headache—Vincristine—peripheral nervous system neoplasm	0.00315	0.00488	CcSEcCtD
Papaverine—PDE10A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.0031	0.00911	CbGpPWpGaD
Papaverine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.0031	0.0048	CcSEcCtD
Papaverine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00304	0.00471	CcSEcCtD
Papaverine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00298	0.00463	CcSEcCtD
Papaverine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00298	0.00462	CcSEcCtD
Papaverine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00297	0.00461	CcSEcCtD
Papaverine—Rash—Cisplatin—peripheral nervous system neoplasm	0.0028	0.00434	CcSEcCtD
Papaverine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.0028	0.00434	CcSEcCtD
Papaverine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00278	0.00432	CcSEcCtD
Papaverine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00276	0.00428	CcSEcCtD
Papaverine—PDE10A—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00273	0.00802	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.0027	0.00793	CbGpPWpGaD
Papaverine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00264	0.00409	CcSEcCtD
Papaverine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00259	0.00402	CcSEcCtD
Papaverine—Rash—Etoposide—peripheral nervous system neoplasm	0.00256	0.00398	CcSEcCtD
Papaverine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00256	0.00398	CcSEcCtD
Papaverine—Headache—Etoposide—peripheral nervous system neoplasm	0.00255	0.00395	CcSEcCtD
Papaverine—PDE10A—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00253	0.00744	CbGpPWpGaD
Papaverine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00252	0.00391	CcSEcCtD
Papaverine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00251	0.0039	CcSEcCtD
Papaverine—PDE3B—IRS-mediated signalling—NRAS—peripheral nervous system neoplasm	0.00249	0.00733	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00245	0.0072	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—NRAS—peripheral nervous system neoplasm	0.00242	0.00713	CbGpPWpGaD
Papaverine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00242	0.00375	CcSEcCtD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—NRAS—peripheral nervous system neoplasm	0.0024	0.00706	CbGpPWpGaD
Papaverine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.0024	0.00372	CcSEcCtD
Papaverine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00235	0.00365	CcSEcCtD
Papaverine—PDE3B—Insulin receptor signalling cascade—NRAS—peripheral nervous system neoplasm	0.00234	0.00688	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—NRAS—peripheral nervous system neoplasm	0.00234	0.00688	CbGpPWpGaD
Papaverine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00233	0.00362	CcSEcCtD
Papaverine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00232	0.0036	CcSEcCtD
Papaverine—PDE3B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.0023	0.00677	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00226	0.00664	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—GNAS—peripheral nervous system neoplasm	0.00221	0.0065	CbGpPWpGaD
Papaverine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00217	0.00337	CcSEcCtD
Papaverine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00217	0.00337	CcSEcCtD
Papaverine—PDE10A—Hemostasis—HGF—peripheral nervous system neoplasm	0.00211	0.0062	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.0021	0.00617	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00209	0.00615	CbGpPWpGaD
Papaverine—PDE3B—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.00202	0.00593	CbGpPWpGaD
Papaverine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00201	0.00312	CcSEcCtD
Papaverine—PDE4B—G Protein Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00201	0.00591	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.002	0.00589	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00199	0.00586	CbGpPWpGaD
Papaverine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00198	0.00308	CcSEcCtD
Papaverine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00303	CcSEcCtD
Papaverine—PDE3B—Signaling by Insulin receptor—NRAS—peripheral nervous system neoplasm	0.00194	0.00571	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00191	0.00561	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.0019	0.0056	CbGpPWpGaD
Papaverine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00188	0.00292	CcSEcCtD
Papaverine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00183	0.00285	CcSEcCtD
Papaverine—PDE10A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00183	0.00538	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00183	0.00537	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—HRAS—peripheral nervous system neoplasm	0.00182	0.00536	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00181	0.00533	CbGpPWpGaD
Papaverine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.0028	CcSEcCtD
Papaverine—PDE3B—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.00178	0.00523	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—HRAS—peripheral nervous system neoplasm	0.00177	0.00521	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00177	0.00519	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—HRAS—peripheral nervous system neoplasm	0.00176	0.00517	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00175	0.00513	CbGpPWpGaD
Papaverine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.0027	CcSEcCtD
Papaverine—PDE4B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00174	0.00511	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—HRAS—peripheral nervous system neoplasm	0.00171	0.00503	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—HRAS—peripheral nervous system neoplasm	0.00171	0.00503	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00164	0.00481	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00161	0.00473	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.0016	0.0047	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00159	0.00467	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00158	0.00466	CbGpPWpGaD
Papaverine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00156	0.00242	CcSEcCtD
Papaverine—PDE10A—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.00154	0.00452	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00151	0.00444	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00149	0.00438	CbGpPWpGaD
Papaverine—PDE4B—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.00147	0.00432	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00146	0.0043	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00145	0.00427	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00145	0.00425	CbGpPWpGaD
Papaverine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00224	CcSEcCtD
Papaverine—PDE3A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00144	0.00424	CbGpPWpGaD
Papaverine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00223	CcSEcCtD
Papaverine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00223	CcSEcCtD
Papaverine—PDE3B—Hemostasis—GNAS—peripheral nervous system neoplasm	0.00143	0.00421	CbGpPWpGaD
Papaverine—Headache—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00222	CcSEcCtD
Papaverine—PDE3B—Signaling by Insulin receptor—HRAS—peripheral nervous system neoplasm	0.00142	0.00418	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.0014	0.00411	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00137	0.00404	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—HGF—peripheral nervous system neoplasm	0.00136	0.00401	CbGpPWpGaD
Papaverine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00135	0.0021	CcSEcCtD
Papaverine—PDE10A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00134	0.00392	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00133	0.00392	CbGpPWpGaD
Papaverine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00206	CcSEcCtD
Papaverine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00206	CcSEcCtD
Papaverine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00205	CcSEcCtD
Papaverine—PDE3A—Hemostasis—GNAS—peripheral nervous system neoplasm	0.0013	0.00383	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00127	0.00373	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00127	0.00372	CbGpPWpGaD
Papaverine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00194	CcSEcCtD
Papaverine—PDE3A—Hemostasis—HGF—peripheral nervous system neoplasm	0.00124	0.00365	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00124	0.00363	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00118	0.00348	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00113	0.00331	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00108	0.00317	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00107	0.00315	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00103	0.00304	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00103	0.00302	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.001	0.00295	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000995	0.00292	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000942	0.00277	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00094	0.00276	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000936	0.00275	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000924	0.00272	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000906	0.00266	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000905	0.00266	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000896	0.00263	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000882	0.00259	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000864	0.00254	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000858	0.00252	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000856	0.00252	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000853	0.00251	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000824	0.00242	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000822	0.00242	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000817	0.0024	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000814	0.00239	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000811	0.00238	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000787	0.00231	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000784	0.0023	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00075	0.0022	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000748	0.0022	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000748	0.0022	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000712	0.00209	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—TP53—peripheral nervous system neoplasm	0.000707	0.00208	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000676	0.00199	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000649	0.00191	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000598	0.00176	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000597	0.00176	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000591	0.00174	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000571	0.00168	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000562	0.00165	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000555	0.00163	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000545	0.0016	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000531	0.00156	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000529	0.00155	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000521	0.00153	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00052	0.00153	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000506	0.00149	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000495	0.00145	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000485	0.00143	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000482	0.00142	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000481	0.00141	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000458	0.00135	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—TP53—peripheral nervous system neoplasm	0.000458	0.00135	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000442	0.0013	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000438	0.00129	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00042	0.00124	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TP53—peripheral nervous system neoplasm	0.000417	0.00123	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000412	0.00121	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000399	0.00117	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000388	0.00114	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000386	0.00114	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000377	0.00111	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000374	0.0011	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000352	0.00103	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000343	0.00101	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000343	0.00101	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000337	0.000992	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000313	0.000921	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000313	0.000919	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000307	0.000903	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000297	0.000874	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000292	0.000859	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000292	0.000858	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000267	0.000784	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000251	0.000738	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000244	0.000718	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000243	0.000714	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000242	0.000711	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.00024	0.000705	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000231	0.000679	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000229	0.000674	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000229	0.000672	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000222	0.000654	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000222	0.000652	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00022	0.000648	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000218	0.00064	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000212	0.000622	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00021	0.000616	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000203	0.000596	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000202	0.000595	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000202	0.000594	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000192	0.000565	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000189	0.000555	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000185	0.000543	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000176	0.000516	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000172	0.000506	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000164	0.000481	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000155	0.000456	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000148	0.000436	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000141	0.000415	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000135	0.000397	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000134	0.000395	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000131	0.000385	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000129	0.000378	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000119	0.000351	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000113	0.000334	CbGpPWpGaD
